title: Fenretinide as an anti-angiogenic agent in neuroblastoma.
abstract: Angiogenesis is a critical event in the progression of human neuroblastoma. This mini-review summarizes our literature and experimental data concerning the use of anti-angiogenic molecules, such as TNP-470 and fenretinide, in neuroblastoma treatment.
authors.affiliation: Department of Human Anatomy and Histology, University of Bari Medical School, Policlinico, 11 I-70124 Bari, Italy. ribatti@anatomia.uniba.it
authors.forename: Domenico
authors.initials: D
authors.lastname: Ribatti
authors.forename: Lizzia
authors.initials: L
authors.lastname: Raffaghello
authors.forename: Danilo
authors.initials: D
authors.lastname: Marimpietri
authors.forename: Emilio
authors.initials: E
authors.lastname: Cosimo
authors.forename: P Giuseppe
authors.initials: PG
authors.lastname: Montaldo
authors.forename: Beatrice
authors.initials: B
authors.lastname: Nico
authors.forename: Angelo
authors.initials: A
authors.lastname: Vacca
authors.forename: Mirco
authors.initials: M
authors.lastname: Ponzoni
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017313:Fenretinide / Q000627:therapeutic use*; D006801:Humans; D009389:Neovascularization, Pathologic / Q000517:prevention & control*; D009447:Neuroblastoma / Q000098:blood supply* / Q000188:drug therapy
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D017313:Fenretinide